Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/27306
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmarachi, Adaeze Uzoma-
dc.contributor.authorSokolnikova, Nelia-
dc.date.accessioned2020-11-16T19:12:05Z-
dc.date.available2020-11-16T19:12:05Z-
dc.date.issued2020-
dc.identifier.citationAmaranchi A. Effect of lyraglutide on the lipid profile in patients with type 2 diabetes / A. Amaranchi, N. Sokolnikova // ISIC-2020 : [International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, 8–9 October, 2020] : abstract book / KNMU. – Kharkiv, 2020. – P. 57–58.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/27306-
dc.description.abstractType 2 diabetes mellitus is a complex metabolic disorder which characterized be carbohydrate, protein and lipid metabolism disorder due to target tissue resistance to insulin and its cellular metabolic effect. Obesity-dependent diabetes can significantly decrease life expectance. Diabetes mellitus type 2 accounts for about 90% to 95% of cases and the recent explosion of diabetes has aggravated insulin resistance and contributed greatly to the diabetes epidemic. Excess fat causes cells to be less responsive to insulin. In obese individuals, adipose tissue secretes excess of non-esterified fatty acids and other substances that affect metabolism such as glycerol, hormones, proinflammatory cytokines, leptin and others.en_US
dc.language.isoenen_US
dc.subjectlyraglutideen_US
dc.subjectdiabetes mellitus type 2en_US
dc.subjectlipid profileen_US
dc.titleEffect of lyraglutide on the lipid profile in patients with type 2 diabetesen_US
dc.typeThesisen_US
Appears in Collections:Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 3 та ендокринології

Files in This Item:
File Description SizeFormat 
Amarachi Adaeze Uzoma.pdf116,43 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.